Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H34F3N7O4S |
Molecular Weight | 597.653 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1CN(C2=NC(=CC=C2C(=O)NS(=O)(=O)C3=CN(C)N=C3C)N4C=CC(OCC(C)(C)C(F)(F)F)=N4)C(C)(C)C1
InChI
InChIKey=MVRHVFSOIWFBTE-INIZCTEOSA-N
InChI=1S/C26H34F3N7O4S/c1-16-12-25(5,6)35(13-16)22-18(23(37)33-41(38,39)19-14-34(7)31-17(19)2)8-9-20(30-22)36-11-10-21(32-36)40-15-24(3,4)26(27,28)29/h8-11,14,16H,12-13,15H2,1-7H3,(H,33,37)/t16-/m0/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/18/2116
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
||
|
FDA ORPHAN DRUG |
647618
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID901027907
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
DB15444
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
RRN67GMB0V
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
134587348
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
2256951
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
FG-200
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
11180
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
100000177684
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
RRN67GMB0V
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
5372
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
2216712-66-0
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
m12166
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
Elexacaftor, Tezacaftor and Ivacaftor
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
C169935
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY | |||
|
Elexacaftor
Created by
admin on Sat Dec 16 13:22:36 GMT 2023 , Edited by admin on Sat Dec 16 13:22:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY